Do the Stepan (SCL) awards to Afonso Galimberti involve any open-market share purchases or sales?

No. The filing shows only grants classified as derivative awards: performance shares, restricted stock units, and stock appreciation rights. All transactions use code A for grant or award acquisition, meaning they are compensation grants rather than market trades.

Stepan VP granted performance shares and RSUs

Stepan Company VP and GM Surfactants NA Afonso Adriano Jose Galimberti received new equity-based awards as part of his compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Stepan Company VP and GM Surfactants NA Afonso Adriano Jose Galimberti received new equity-based awards as part of his compensation. On April 13, 2026, he was granted 1,310 performance shares, 2,621 restricted stock units, and 3,694 stock appreciation rights with a $52.46 exercise price. The performance shares vest if Stepan meets performance goals for the period ending December 31, 2028. The restricted stock units vest ratably over three years beginning on the grant date.

Insider Trade Summary

Grant/Award: 7,625 shares

Grant/Award 3 txns

Insider Galimberti Afonso Adriano Jose

Role VP and GM Surfactants NA

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares	1,310	$0.00	$0.00
Grant/Award	Restricted Stock Units	2,621	$0.00	$0.00
Grant/Award	Stock Appreciation Right	3,694	$0.00	$0.00

Holdings After Transaction: Performance Shares — 1,310 contracts (Direct); Restricted Stock Units — 2,621 contracts (Direct); Stock Appreciation Right — 3,694 contracts (Direct)

Footnotes (4)

F1. Each performance share represents a contingent right to receive one share of Stepan Company common stock.
F2. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
F3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
F4. Vests ratably over three years beginning on the date shown.

Key Figures

Performance share grant: 1,310 shares RSU grant: 2,621 units Stock appreciation rights: 3,694 rights +5 more

8 metrics

Performance share grant 1,310 shares Performance shares granted April 13, 2026

RSU grant 2,621 units Restricted stock units granted April 13, 2026

Stock appreciation rights 3,694 rights Stock appreciation right grant April 13, 2026

SAR exercise price $52.46 per share Conversion or exercise price for stock appreciation rights

Performance period end December 31, 2028 End of performance period for performance shares vesting

RSU vesting schedule 3 years RSUs vest ratably over three years from April 13, 2026

SAR exercisable from April 13, 2027 Exercise date for stock appreciation rights

SAR expiration April 13, 2036 Expiration date for stock appreciation rights

Key Terms

Performance Shares, Restricted Stock Units, Stock Appreciation Right, vests ratably over three years, +1 more

5 terms

Performance Shares financial

"Each performance share represents a contingent right to receive one share of Stepan Company common stock."

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Appreciation Right financial

"Stock Appreciation Right derivative award with an exercise price of 52.4600."

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

vests ratably over three years financial

"Vests ratably over three years beginning on the date shown."

performance period ending December 31, 2028 financial

"The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Stepan (SCL) report for Afonso Galimberti?

Stepan reported that VP and GM Surfactants NA Afonso Galimberti received equity awards on April 13, 2026, including performance shares, restricted stock units, and stock appreciation rights. These are compensation-related grants, not open-market stock purchases or sales.

How many performance shares did Afonso Galimberti receive from Stepan (SCL)?

He received 1,310 performance shares, each representing a contingent right to one share of Stepan common stock. These performance shares vest only if Stepan achieves specified performance goals for the period ending December 31, 2028, as outlined in the award terms.

What restricted stock unit grant did Stepan (SCL) make to Afonso Galimberti?

Stepan granted 2,621 restricted stock units to Afonso Galimberti. Each RSU is a contingent right to receive one share of Stepan common stock, and this award vests ratably over three years starting on April 13, 2026, the grant date.

What stock appreciation rights did Stepan (SCL) grant and at what exercise price?

Stepan granted 3,694 stock appreciation rights tied to its common stock, with a conversion or exercise price of $52.46 per share. These rights become exercisable beginning April 13, 2027, and are scheduled to expire on April 13, 2036, if not exercised.

When do the Stepan (SCL) equity awards to Afonso Galimberti vest?

The performance shares vest after Stepan certifies achievement of performance goals for the period ending December 31, 2028. The restricted stock units vest in equal portions over three years starting April 13, 2026, while the stock appreciation rights become exercisable beginning April 13, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/15/2026 - 04:25 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Galimberti Afonso Adriano Jose

(Last)

(First)

(Middle)

1101 SKOKIE BLVD, SUITE 500

(Street)

NORTHBROOK

ILLINOIS

60062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP and GM Surfactants NA

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Performance Shares	⁽¹⁾	04/13/2026		A		1,310		⁽²⁾	⁽²⁾	Common Stock	1,310	$0	1,310	D
Restricted Stock Units	⁽³⁾	04/13/2026		A		2,621		04/13/2027⁽⁴⁾	04/13/2029	Restricted Stock Units	2,621	$0	2,621	D
Stock Appreciation Right	$52.46	04/13/2026		A		3,694		04/13/2027⁽⁴⁾	04/13/2036	Common Stock	3,694	$0	3,694	D

Explanation of Responses:

1. Each performance share represents a contingent right to receive one share of Stepan Company common stock.

2. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.

3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

4. Vests ratably over three years beginning on the date shown.

	/s/ James A. Hart, attorney-in-fact for Mr. Adriano Jose Galimberti Afonso	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR